Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 38,192 |
|
|||||
| News | - | ||||||
| Day High | 2.50 | Low High |
|||||
| Day Low | 2.09 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genprex Inc | GNPX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0894 | -4.03% | 2.13 | 16:17:47 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.23 | 2.09 | 2.50 | 2.13 | 2.2194 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 288 | 38,192 | $ 2.28 | $ 87,148 | - | 2.09 - 45.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:03:36 | 4 | $ 2.23 | USD |
Genprex Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.16M | 1.49M | - | 0 | -30.86M | -20.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Genprex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GNPX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.78 | 2.8699 | 2.09 | 2.36 | 22,102 | -0.65 | -23.38% |
| 1 Month | 3.00 | 3.27 | 2.09 | 2.88 | 42,978 | -0.87 | -29.00% |
| 3 Months | 9.20 | 13.00 | 2.09 | 8.15 | 317,646 | -7.07 | -76.85% |
| 6 Months | 12.80 | 14.796 | 2.09 | 8.94 | 343,280 | -10.67 | -83.36% |
| 1 Year | 44.00 | 45.20 | 2.09 | 22.87 | 461,257 | -41.87 | -95.16% |
| 3 Years | 157.60 | 166.40 | 2.09 | 98.47 | 868,808 | -155.47 | -98.65% |
| 5 Years | 70.00 | 308.80 | 2.09 | 117.67 | 1,274,952 | -67.87 | -96.96% |
Genprex Description
| Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex's oncology program utilizes its systemic, non-viral Oncoprex® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. |
